Center for Human Genetics, University of Bremen, Bremen, Germany.
Genes Chromosomes Cancer. 2012 Apr;51(4):402-8. doi: 10.1002/gcc.21925. Epub 2011 Dec 16.
The t(2;3)(q13;p25) occurs in a subgroup of follicular-patterned thyroid tumors and leads to a fusion of the genes encoding for the thyroid-specific transcription factor paired box 8 (PAX8) and the peroxisome proliferator-activated receptor gamma (PPARγ). Although initially discovered in follicular carcinomas (FTC), the fusion transcripts were also detected in a small fraction of follicular adenomas and rarely in follicular variants of papillary carcinomas (FV-PTC). In most RT-PCR based studies, fresh or snap-frozen tissue samples were used. The aim of the present study was to develop a method for the detection of chimeric PAX8-PPARG transcripts in formalin-fixed paraffin-embedded (FFPE) thyroid tumor samples by conventional RT-PCR. For this purpose, RNA from FFPE samples of 21 FTC, seven FV-PTC, and one bone metastasis derived from an FTC was subjected to RT-PCR with subsequent gel electrophoretic separation of the products. Fusion transcripts were detected in 2/21 primary FTC (9.5%) and in the bone metastasis, but they were undetectable in all seven FV-PTC under investigation. The RT-PCR approach described herein allows to detect all known variants of PAX8-PPARG fusion transcripts and is applicable to FFPE tissues. Thus, it can be used to screen archival thyroid tumor samples for the gene fusion.
t(2;3)(q13;p25) 易位发生在滤泡型甲状腺肿瘤亚组中,导致甲状腺特异性转录因子配对盒 8 (PAX8) 和过氧化物酶体增殖物激活受体 γ (PPARγ) 基因融合。虽然最初在滤泡状癌 (FTC) 中发现,但融合转录本也在一小部分滤泡性腺瘤和罕见的滤泡状甲状腺癌滤泡型变异 (FV-PTC) 中检测到。在大多数基于 RT-PCR 的研究中,使用了新鲜或速冻组织样本。本研究的目的是开发一种通过常规 RT-PCR 检测福尔马林固定石蜡包埋 (FFPE) 甲状腺肿瘤样本中嵌合 PAX8-PPARG 转录本的方法。为此,对 21 例 FTC、7 例 FV-PTC 和 1 例源自 FTC 的骨转移的 FFPE 样本中的 RNA 进行 RT-PCR,随后对产物进行凝胶电泳分离。融合转录本在 2/21 例原发性 FTC(9.5%)和骨转移中检测到,但在所有 7 例研究的 FV-PTC 中均未检测到。本文描述的 RT-PCR 方法可检测到所有已知的 PAX8-PPARG 融合转录本变体,适用于 FFPE 组织。因此,它可用于筛选存档的甲状腺肿瘤样本中的基因融合。